Neoleukin Therapeutics, Inc. - Common Stock (NQ:NLTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 18, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	3.460 (1)
Ask (Size)	3.590 (5)
Prev. Close	3.490
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	42,425,071
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

December 14, 2023

From Neoleukin Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 05, 2023

Via Benzinga

Performance

More News

Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket ↗

October 05, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 05, 2023

Via InvestorPlace

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

September 22, 2023

From Neoleukin Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 17, 2023

Via Benzinga

NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX

July 25, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Great Ajax Corp. (NYSE – AJX)

July 24, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Kaleyra, Inc. (NYSE – KLR), Great Ajax Corp. (NYSE – AJX)

July 18, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Neoleukin Therapeutics To Merge With Neurogene: Creates Biotech Firm Focused On Genetic Medicines For Neurological Diseases ↗

July 18, 2023

Via Benzinga

NLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders

July 18, 2023

From Halper Sadeh LLC

Via Business Wire

Neurogene and Neoleukin Announce Definitive Merger Agreement

July 18, 2023

From Neoleukin Therapeutics, Inc.

Via GlobeNewswire

US Stocks Turn Lower; S&P 500 Down 1% ↗

March 09, 2023

Via Benzinga

Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 09, 2023

Via Benzinga

US Stocks Pare Gains; BJ's Wholesale Club Earnings Top Views ↗

March 09, 2023

Via Benzinga

Neoleukin Therapeutics Seeks Strategic Alternatives, To Layoff More In Round 2 Within 6 Months ↗

March 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 09, 2023

Via Benzinga

Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

March 09, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 09, 2023

Via InvestorPlace

Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition

March 08, 2023

From Neoleukin Therapeutics, Inc.

Via GlobeNewswire

Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting

December 12, 2022

From Neoleukin Therapeutics, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

November 16, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022 ↗

November 16, 2022

Via Benzinga

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗

November 16, 2022

Via Benzinga

Frequently Asked Questions

Is Neoleukin Therapeutics, Inc. - Common Stock publicly traded?

Yes, Neoleukin Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Neoleukin Therapeutics, Inc. - Common Stock trade on?

Neoleukin Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Neoleukin Therapeutics, Inc. - Common Stock?

The ticker symbol for Neoleukin Therapeutics, Inc. - Common Stock is NLTX on the Nasdaq Stock Market